Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
387
archived clinical trials in
Iron Deficiency Anemia

Adherence With Iron Sprinkles Among High-Risk Infants
Adherence With Iron Sprinkles Among High-Risk Infants
Status: Enrolling
Updated:  2/2/2016
Boston Medical Center Pediatric Primary Care Clinic
642
mi
from 43215
Boston, MA
Adherence With Iron Sprinkles Among High-Risk Infants
Adherence With Iron Sprinkles Among High-Risk Infants
Status: Enrolling
Updated: 2/2/2016
Boston Medical Center Pediatric Primary Care Clinic
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Status: Enrolling
Updated:  4/1/2016
Providence Medical Research Center
1779
mi
from 43215
Spokane, WA
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Status: Enrolling
Updated: 4/1/2016
Providence Medical Research Center
1779
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia
A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia
Status: Enrolling
Updated:  1/30/2017
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia
A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia
Status: Enrolling
Updated: 1/30/2017
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Iron Deficiency in Female State Fair Attendees
Iron Deficiency, Depression, and Other Affective Disorders in Female State Fair Attendees
Status: Enrolling
Updated:  8/2/2017
University of Minnesota - Department of Food Science and Nutrition
622
mi
from 43215
Saint Paul, MN
Iron Deficiency in Female State Fair Attendees
Iron Deficiency, Depression, and Other Affective Disorders in Female State Fair Attendees
Status: Enrolling
Updated: 8/2/2017
University of Minnesota - Department of Food Science and Nutrition
622
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
1942
mi
from 43215
La Mesa, CA
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
1942
mi
from 43215
La Mesa, CA
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
767
mi
from 43215
Edgewater, FL
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
767
mi
from 43215
Edgewater, FL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
993
mi
from 43215
Miami, FL
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
1725
mi
from 43215
Meridian, ID
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
1725
mi
from 43215
Meridian, ID
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
272
mi
from 43215
Evergreen Park, IL
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
272
mi
from 43215
Evergreen Park, IL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
563
mi
from 43215
Springfield, MA
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
563
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
185
mi
from 43215
Pontiac, MI
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
185
mi
from 43215
Pontiac, MI
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
1938
mi
from 43215
Reno, NV
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
1938
mi
from 43215
Reno, NV
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
492
mi
from 43215
Great Neck, NY
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
496
mi
from 43215
Mineola, NY
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
496
mi
from 43215
Mineola, NY
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
302
mi
from 43215
Asheville, NC
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
302
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
484
mi
from 43215
Wilmington, NC
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
484
mi
from 43215
Wilmington, NC
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
463
mi
from 43215
Orangeburg, SC
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
463
mi
from 43215
Orangeburg, SC
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
991
mi
from 43215
Houston, TX
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Status: Enrolling
Updated:  10/3/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 10/3/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Nondialysis-dependent Chronic Kidney Disease
Status: Enrolling
Updated:  10/3/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Nondialysis-dependent Chronic Kidney Disease
Status: Enrolling
Updated: 10/3/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
An Open-Label Extension Study of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Status: Enrolling
Updated:  10/3/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
An Open-Label Extension Study of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 10/3/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose in a Non-Dialysis Dependent Population
Status: Enrolling
Updated:  10/16/2017
Robert Packer Hospital
366
mi
from 43215
Sayre, PA
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose in a Non-Dialysis Dependent Population
Status: Enrolling
Updated: 10/16/2017
Robert Packer Hospital
366
mi
from 43215
Sayre, PA
Click here to add this to my saved trials
A Phase IV Trial of Repeated Doses of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease on Hemodialysis
Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, With MRI Substudy, of Repeated Doses of Ferumoxytol Compared With Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Status: Enrolling
Updated:  11/14/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
A Phase IV Trial of Repeated Doses of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease on Hemodialysis
Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, With MRI Substudy, of Repeated Doses of Ferumoxytol Compared With Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Status: Enrolling
Updated: 11/14/2017
AMAG Pharmaceuticals, Inc.
633
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia
A Single-center, Double-blinded, Randomized, 12 Week, Superiority Study in Infants and Young Children to Compare the Efficacy of NovaFerrum® Versus Ferrous Sulfate in the Treatment of Nutritional Iron Deficiency Anemia.
Status: Enrolling
Updated:  11/15/2017
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia
A Single-center, Double-blinded, Randomized, 12 Week, Superiority Study in Infants and Young Children to Compare the Efficacy of NovaFerrum® Versus Ferrous Sulfate in the Treatment of Nutritional Iron Deficiency Anemia.
Status: Enrolling
Updated: 11/15/2017
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Assessment of Safety of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Status: Enrolling
Updated:  1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Assessment of Safety of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Status: Enrolling
Updated: 1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
Status: Enrolling
Updated:  1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
Status: Enrolling
Updated: 1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Iron Deficient Patients With Fibromyalgia
Status: Enrolling
Updated:  1/22/2018
Clinical Research Solutions
348
mi
from 43215
Franklin, TN
Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Iron Deficient Patients With Fibromyalgia
Status: Enrolling
Updated: 1/22/2018
Clinical Research Solutions
348
mi
from 43215
Franklin, TN
Click here to add this to my saved trials
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
A Multi-center, Randomized, Active Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
Status: Enrolling
Updated:  1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
A Multi-center, Randomized, Active Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
Status: Enrolling
Updated: 1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
Randomized Evaluation of Efficacy and Safety of Ferric Carboxymaltose in Patients With Iron Deficiency Anemia and Impaired Renal Function
Status: Enrolling
Updated:  1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
Randomized Evaluation of Efficacy and Safety of Ferric Carboxymaltose in Patients With Iron Deficiency Anemia and Impaired Renal Function
Status: Enrolling
Updated: 1/22/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
A Randomized, Controlled Study to Investigate the Safety and Oxidative Stress Potential of Intravenous Ferric Carboxymaltose (FCM) vs. IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
Status: Enrolling
Updated:  2/2/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
A Randomized, Controlled Study to Investigate the Safety and Oxidative Stress Potential of Intravenous Ferric Carboxymaltose (FCM) vs. IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
Status: Enrolling
Updated: 2/2/2018
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
Status: Enrolling
Updated:  2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
Status: Enrolling
Updated: 2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials